Cancer can now be cured by editing your DNA!

Thanks to biotech, a $1 trillion market that is transforming healthcare and the economy by 2025.

CRISPR, a revolutionary gene-editing technology, can fix DNA and fight diseases directly. In 2023, the first CRISPR-based therapy, Casgevy, was approved for treating sickle cell disease and beta-thalassemia. By 2025, CRISPR could also treat cancer, heart diseases, and rare genetic problems!

The global CRISPR market, worth $3.3 billion now, is expected to reach $8.8 billion by 2028!

mRNA vaccines, which saved lives during COVID-19, are now being used for cancer treatment too. Moderna and Merck's mRNA-4157 vaccine is already in Phase III trials for lung cancer.

Precision medicine is also growing with treatments made specially for each person's genetic makeup. Thanks to AI and genomics, doctors can now predict diseases and offer better cures.

However, biotech is becoming a global race. The US, EU, and China are competing for dominance. And sadly, poorer countries are being left behind.

The big question is: Will biotech be for everyone, or only for the rich?

India's biotech industry is growing fast and we have a big role to play!